Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Comparing the efficacy of pulsed dye laser, Q-Switched Nd-YAG, CO2, and combined CO(2) and Q-Switched Nd-YAG lasers for the treatment of cutaneous macular amyloidosis.
Radmanesh M, Ghanatir F, Radmanesh R. Radmanesh M, et al. J Dermatolog Treat. 2021 Mar;32(2):258-260. doi: 10.1080/09546634.2019.1654071. Epub 2019 Aug 25. J Dermatolog Treat. 2021. PMID: 31415215
BACKGROUND: No topical and systemic treatment is proven to be effective on Cutaneous Macular Amyloidosis (CMA). The physical removal of the deposited protein by lasers may be a better choice. OBJECTIVE: To compare the efficacy of different lasers including Pu …
BACKGROUND: No topical and systemic treatment is proven to be effective on Cutaneous Macular Amyloidosis (CMA). The phy …
Comparative study of fractional CO2 laser and fractional CO2 laser-assisted drug delivery of topical steroid and topical vitamin C in macular amyloidosis.
Sobhi RM, Sharaoui I, El Nabarawy EA, El Nemr Esmail RS, Hegazy RA, Aref DHF. Sobhi RM, et al. Lasers Med Sci. 2018 May;33(4):909-916. doi: 10.1007/s10103-018-2457-1. Epub 2018 Feb 26. Lasers Med Sci. 2018. PMID: 29480422
To determine the effect of fractional CO(2) laser in macular amyloidosis in comparison to fractional CO(2) laser-assisted drug delivery of topical steroids and topical vitamin C, the study includes 10 female patients with cutaneous macular amyloidosis aged be …
To determine the effect of fractional CO(2) laser in macular amyloidosis in comparison to fractional CO(2) laser-assisted drug delivery of t …
The therapeutic effects of 1540-nm nonablative fractional erbium laser on macular amyloidosis: a randomized clinical trial.
Nahidi Y, Delghandi SR, Kiafar B, Saki A. Nahidi Y, et al. J Dermatolog Treat. 2021 May;32(3):340-344. doi: 10.1080/09546634.2019.1655136. Epub 2019 Aug 29. J Dermatolog Treat. 2021. PMID: 31411528 Clinical Trial.
OBJECTIVE: This aim of this study was to determine the effect of 1540-nm nonablative fractional erbium on macular amyloidosis. METHODS: This phase-II clinical trial study has been performed with parallel group with blinding of the evaluator. The skin lesions of the …
OBJECTIVE: This aim of this study was to determine the effect of 1540-nm nonablative fractional erbium on macular amyloidosis. METHODS: This …
Efficacy of topical gabapentin in women with primary macular amyloidosis: A side-by-side triple-blinded randomized clinical trial.
Abtahi-Naeini B, Hemati E, Faghihi G, Shahmoradi Z, Paknazar F, Rastegarnasab F, Varshosaz J, Hadian M, Akbari M, Sabzghabaee AM. Abtahi-Naeini B, et al. J Cosmet Dermatol. 2024 May;23(5):1677-1684. doi: 10.1111/jocd.16180. Epub 2024 Jan 30. J Cosmet Dermatol. 2024. PMID: 38291677 Clinical Trial.
BACKGROUND: Primary cutaneous macular amyloidosis (PCMA) is a chronic pruritic cutaneous disease characterized by heterogeneous extracellular deposition of amyloid protein in the skin. AIMS: This study aimed to evaluate the efficacy of topical 6% gabapentin c …
BACKGROUND: Primary cutaneous macular amyloidosis (PCMA) is a chronic pruritic cutaneous disease characterized by heter …